Masked Hypertension in Healthy Children and Adolescents: Who Should Be Screened?
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, přehledy, práce podpořená grantem
PubMed
37639176
PubMed Central
PMC10491704
DOI
10.1007/s11906-023-01260-6
PII: 10.1007/s11906-023-01260-6
Knihovny.cz E-zdroje
- Klíčová slova
- ABPM, Ambulatory blood pressure monitoring, BP, Blood pressure, LVH, Left ventricular hypertrophy, MH, Masked hypertension,
- MeSH
- chronická renální insuficience * MeSH
- dítě MeSH
- hypertenze * diagnóza epidemiologie MeSH
- lidé MeSH
- maskovaná hypertenze * diagnóza epidemiologie MeSH
- mladiství MeSH
- obezita MeSH
- rizikové faktory MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mladiství MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
PURPOSE OF REVIEW: The goal is to review masked hypertension (MH) as a relatively new phenomenon when patients have normal office BP but elevated out-of-office BP. Firstly, it was described in children in 2004. It has received increased attention in the past decade. RECENT FINDINGS: The prevalence of MH in different pediatric populations differs widely between 0 and 60% based on the population studied, definition of MH, or method of out-of-office BP measurement. The highest prevalence of MH has been demonstrated in children with chronic kidney disease (CKD), obesity, diabetes, and after heart transplantation. In healthy children but with risk factors for hypertension such as prematurity, overweight/obesity, diabetes, chronic kidney disease, or positive family history of hypertension, the prevalence of MH is 9%. In healthy children without risk factors for hypertension, the prevalence of MH is very low ranging 0-3%. In healthy children, only patients with the following clinical conditions should be screened for MH: high-normal/elevated office BP, positive family history of hypertension, and those referred for suspected hypertension who have normal office BP in the secondary/tertiary center.
Department of Pediatrics Medical Faculty University of Ostrava Ostrava Czech Republic
Department of Pediatrics University Hospital Ostrava Ostrava Czech Republic
Zobrazit více v PubMed
Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension. 2002;40:795–796. doi: 10.1161/01.HYP.0000038733.08436.98. PubMed DOI
Matsuoka S, Awazu M. Masked hypertension in children and young adults. Pediatr Nephrol. 2004;19:651–654. doi: 10.1007/s00467-004-1459-3. PubMed DOI
Lurbe E, Torro I, Alvarez V, Nawrot T, Paya R, Redon J, Staessen JA. Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension. 2005;45:493–498. doi: 10.1161/01.HYP.0000160320.39303.ab. PubMed DOI
Lurbe E. Masked hypertension in children and adolescents. Curr Hypertens Rep. 2008;10:165–166. doi: 10.1007/s11906-008-0030-1. PubMed DOI
Stabouli S, Kotsis V, Toumanidis S, Papamichael C, Constantopoulos A, Zakopoulos N. White-coat and masked hypertension in children: association with target-organ damage. Pediatr Nephrol. 2005;20:1151–1155. doi: 10.1007/s00467-005-1979-5. PubMed DOI
Pickering TG, Eguchi K, Kario K. Masked hypertension: a review. Hypertens Res. 2007;30:479–488. doi: 10.1291/hypres.30.479. PubMed DOI
Anstey DE, Pugliese D, Abdalla M, Bello NA, Givens R, Shimbo D. An update on masked hypertension. Curr Hypertens Rep. 2017;19:94. doi: 10.1007/s11906-017-0792-4. PubMed DOI PMC
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. ESC Scientific Document Group. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104. PubMed
•• Stergiou GS, Palatini P, Parati G, O'Brien E, Januszewicz A, Lurbe E, et al. European Society of Hypertension Council and the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39:1293–302. This is the most recent guidelines for performing out-of-office BP measurement for detection of masked hypertension.
Stergiou GS, Nasothimiou E, Giovas P, Kapoyiannis A, Vazeou A. Diagnosis of hypertension in children and adolescents based on home versus ambulatory blood pressure monitoring. J Hypertens. 2008;26:1556–1562. doi: 10.1097/HJH.0b013e328301c411. PubMed DOI
Wühl E, Hadtstein C, Mehls O, Schaefer F, Escape Trial Group. Home, clinic, and ambulatory blood pressure monitoring in children with chronic renal failure. Pediatr Res. 2004;55:492–7. PubMed
Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016;34:1887–1920. doi: 10.1097/HJH.0000000000001039. PubMed DOI
Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Subcommittee on screening and management of high blood pressure in children. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 2017;140:e20171904. PubMed
Palatini P. How should we manage a patient with masked hypertension? High Blood Press Cardiovasc Prev. 2015;22:11–16. doi: 10.1007/s40292-014-0044-5. PubMed DOI
O'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731–68. PubMed
Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, et al. CKiD Study Group. Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol. 2010;21:137–44. PubMed PMC
Puraswani M, Khandelwal P, Saini H, Saini S, Gurjar BS, Sinha A, et al. Clinical and immunological profile of anti-factor h antibody associated atypical hemolytic uremic syndrome: a nationwide database. Front Immunol. 2019;10:1282. doi: 10.3389/fimmu.2019.01282. PubMed DOI PMC
Massella L, Mekahli D, Paripović D, Prikhodina L, Godefroid N, Niemirska A, et al. Prevalence of hypertension in children with early-stage ADPKD. Clin J Am Soc Nephrol. 2018;13:874–883. doi: 10.2215/CJN.11401017. PubMed DOI PMC
Seeman T, Blažík R, Fencl F, Bláhová K, Obeidová L, Štekrová J, et al. Ambulatory blood pressure and hypertension control in children with autosomal recessive polycystic kidney disease: clinical experience from two central European tertiary centres. J Hypertens. 2022;40:425–431. PubMed
Westland R, Schreuder MF, Bökenkamp A, Spreeuwenberg MD, van Wijk JA. Renal injury in children with a solitary functioning kidney–the KIMONO study. Nephrol Dial Transplant. 2011;26:533–541. doi: 10.1093/ndt/gfq844. PubMed DOI
• Yel S, Günay N, Pınarbaşı AS, Balaban AG, Caferoğlu Z, Dursun İ, Poyrazoğlu MH. Do children with solitary or hypofunctioning kidney have the same prevalence for masked hypertension? Pediatr Nephrol. 2021;36:1833–41.This study shows that children with solitary of hypofunctioning kidney has high prevalence of masked hypertension especially if kidney scarring is present. PubMed
Seeman T, John U, Bláhová K, Vondrichová H, Janda J, Misselwitz J. Ambulatory blood pressure monitoring in children with unilateral multicystic dysplastic kidney. Eur J Pediatr. 2001;160:78–83. doi: 10.1007/s004310000579. PubMed DOI
Seeman T, Patzer L, John U, Dusek J, Vondrák K, Janda J, Misselwitz J. Blood pressure, renal function, and proteinuria in children with unilateral renal agenesis. Kidney Blood Press Res. 2006;29:210–215. doi: 10.1159/000095735. PubMed DOI
Patzer L, Seeman T, Luck C, Wühl E, Janda J, Misselwitz J. Day- and night-time blood pressure elevation in children with higher grades of renal scarring. J Pediatr. 2003;142:117–122. doi: 10.1067/mpd.2003.13. PubMed DOI
Karakaya D, Çakıcı EK, Yazılıtaş F, Güngör T, Çelikkaya E, Bağlan E, Bülbül M. The importance of ambulatory blood pressure monitoring for diagnosing masked hypertension in patients with renal parenchymal scarring. Pediatr Nephrol. 2023;38:1215–1222. doi: 10.1007/s00467-022-05754-4. PubMed DOI
Chu DI, Ehlayel AM, Ginsberg JP, Meyers KE, Benton M, Thomas M, et al. Kidney outcomes and hypertension in survivors of wilms tumor: a prospective cohort study. J Pediatr. 2021;230:215–220. doi: 10.1016/j.jpeds.2020.12.005. PubMed DOI PMC
Seeman T, Pohl M, John U, Dusek J, Vondrák K, Janda J, et al. Ambulatory blood pressure, proteinuria and uric acid in children with IgA nephropathy and their correlation with histopathological findings. Kidney Blood Press Res. 2008;31:337–342. doi: 10.1159/000164800. PubMed DOI
Sarkar S, Sinha A, Lakshmy R, Agarwala A, Saxena A, Hari P, Bagga A. Ambulatory blood pressure monitoring in frequently relapsing nephrotic syndrome. Indian J Pediatr. 2017;84:31–35. doi: 10.1007/s12098-016-2207-y. PubMed DOI
Sethna CB, Ng DK, Jiang S, Saland J, Warady BA, Furth S, Meyers KE. Cardiovascular disease risk among children with focal segmental glomerulosclerosis: a report from the chronic kidney disease in children study. Pediatr Nephrol. 2019;34:1403–1412. doi: 10.1007/s00467-019-04229-3. PubMed DOI PMC
Lingens N, Soergel M, Loirat C, Busch C, Lemmer B, Schärer K. Ambulatory blood pressure monitoring in paediatric patients treated by regular haemodialysis and peritoneal dialysis. Pediatr Nephrol. 1995;9:167–172. doi: 10.1007/BF00860734. PubMed DOI
Chaudhuri A, Sutherland SM, Begin B, Salsbery K, McCabe L, Potter D, et al. Role of twenty-four-hour ambulatory blood pressure monitoring in children on dialysis. Clin J Am Soc Nephrol. 2011;6:870–876. doi: 10.2215/CJN.07960910. PubMed DOI PMC
Paripovic D, Kostic M, Spasojevic B, Kruscic D, Peco-Antic A. Masked hypertension and hidden uncontrolled hypertension after renal transplantation. Pediatr Nephrol. 2010;25:1719–1724. doi: 10.1007/s00467-010-1552-8. PubMed DOI
McGlothan KR, Wyatt RJ, Ault BH, Hastings MC, Rogers T, DiSessa T, Jones DP. Predominance of nocturnal hypertension in pediatric renal allograft recipients. Pediatr Transplant. 2006;10:558–564. doi: 10.1111/j.1399-3046.2006.00521.x. PubMed DOI
• Hamdani G, Nehus EJ, Hooper DK, Mitsnefes MM. Masked hypertension and allograft function in pediatric and young adults kidney transplant recipients. Pediatr Transplant. 2016;20:1026–31. This study clearly showed that children after kidney transplantation have a high prevalence of masked hypertension. PubMed
Hamdani G, Nehus EJ, Hanevold CD, Sebestyen Van Sickle J, Woroniecki R, Wenderfer SE, Hooper DK, Blowey D, Wilson A, Warady BA, Mitsnefes MM. Ambulatory blood pressure, left ventricular hypertrophy, and allograft function in children and young adults after kidney transplantation. Transplantation. 2017;101:150–6. PubMed PMC
Seeman T. Ambulatory blood pressure monitoring in pediatric renal transplantation. Curr Hypertens Rep. 2012;14:608–618. doi: 10.1007/s11906-012-0301-8. PubMed DOI
Seeman T, Pfaff M, Sethna CB. Isolated nocturnal hypertension in pediatric kidney transplant recipients. Pediatr Transplant. 2022;26:e14192. doi: 10.1111/petr.14192. PubMed DOI
Prytula A, Vandekerckhove K, Raes A, De Wolf D, Dehoorne J, VandeWalle J, De Bruyne R. Tacrolimus predose concentration is associated with hypertension in pediatric liver transplant recipients. J Pediatr Gastroenterol Nutr. 2016;63:616–623. doi: 10.1097/MPG.0000000000001141. PubMed DOI
Borchert-Morlins B, Memaran N, Sauer M, Maecker-Kolhoff B, Sykora KW, Blote R, Bauer E, Schmidt BMW, Melk A, Beier R. Cardiovascular risk factors and subclinical organ damage after hematopoietic stem cell transplantation in pediatric age. Bone Marrow Transplant. 2018;53:983–992. doi: 10.1038/s41409-018-0104-x. PubMed DOI
Tainio J, Qvist E, Miettinen J, Holtta T, Pakarinen M, Jahnukainen T, Jalanko H. Blood pressure profiles 5 to 10 years after transplant in pediatric solid organ recipients. J Clin Hypertens. 2015;172:154–161. doi: 10.1111/jch.12465. PubMed DOI PMC
• Bansal N, Raedi WA, Medar SS, Abraham L, Beddows K, Hsu DT, et al. Masked Hypertension in Pediatric Heart Transplant Recipients. Pediatric cardiology. 2023;19. 10.1007/s00246-023-03096-y. Online ahead of print. Most recent study showing that also children after heart transplantation suffer often from masked hypertension. PubMed
Fredric D, Greenberg JH, Parikh CR, Devarajan P, Chui H, Cockovski V, et al. 24-hour ambulatory blood pressure monitoring 9 years after pediatric cardiac surgery: a pilot and feasibility study. Pediatric nephrology (Berlin, Germany) 2021;36(6):1533–1541. doi: 10.1007/s00467-020-04847-2. PubMed DOI PMC
Sendzikaite S, Sudikiene R, Lubaua I, Silis P, Rybak A, Brzezinska-Rajszys G, et al. Antihypertensive therapy of late arterial hypertension in children following successful coarctation correction. J Hypertens. 2022;40(12):2476–2485. doi: 10.1097/HJH.0000000000003282. PubMed DOI
Dubey SRK, Shrivastava N, Sharma T, Bhatt GC, Dhingra B, Pakhare AP, et al. Abnormal ambulatory blood pressure and early renal dysfunction in sickle cell disease. Indian J Pediatr. 2021;88(6):562–567. doi: 10.1007/s12098-020-03558-8. PubMed DOI
Stabouli S, Antza C, Papadopoulou E, Teli A, Kotsis V, Economou M. Unmasking hypertension in children and adolescents with sickle/beta-thalassemia. J Clin Hypertens (Greenwich) 2020;22(8):1444–1449. doi: 10.1111/jch.13957. PubMed DOI PMC
Becker AM, Goldberg JH, Henson M, Ahn C, Tong L, Baum M, et al. Blood pressure abnormalities in children with sickle cell anemia. Pediatr Blood Cancer. 2014;61(3):518–522. doi: 10.1002/pbc.24843. PubMed DOI
Strumph K, Hafeman M, Ranabothu S, Gomes W, Benitez S, Kaskel F, et al. Nocturnal hypertension associated with stroke and silent cerebral infarcts in children with sickle cell disease. Pediatr Blood Cancer. 2021;68(5):e28883. doi: 10.1002/pbc.28883. PubMed DOI
Rawshani A, Sattar N, Franzén S, Rawshani A, Hattersley A, Svensson A, Eliasson B, Gudbjörnsdottir S. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. The Lancet. 2018;392:477–486. doi: 10.1016/S0140-6736(18)31506-X. PubMed DOI PMC
Dost A, Bechtold S, Fink K, Bonfig W, Wiemann D, Kapellen T, Witsch M, Schwab K, Holl R. 2017 American Academy of Pediatrics Clinical Practice Guideline: impact on prevalence of arterial hypertension in children and adolescents with type 1 diabetes. Diabetes Care. 2020;43:1311–1318. doi: 10.2337/dc19-2022. PubMed DOI
Šuláková T, Janda J, Černá J, Janštová V, Šuláková A, Slaný J, Feber J. Arterial HTN in children with T1DM-frequent and not easy to diagnose. Pediatr Diabetes. 2009;10:441–448. doi: 10.1111/j.1399-5448.2009.00514.x. PubMed DOI
Basiratnia M, Abadi S, Amirhakimi G, Karamizadeh Z. Karamifar H Ambulatory blood pressure monitoring in children and adolescents with type-1 diabetes mellitus and its relation to diabetic control and microalbuminuria. Saudi J Kidney Dis Transpl. 2012;23:311–315. PubMed
Narkiewicz K, Kjeldsen S, Egan B, Kreutz R, Burnier M. Masked hypertension in type 2 diabetes: never take normotension for granted and always assess out-of-office blood pressure. Blood Press. 2022;31:207–209. doi: 10.1080/08037051.2022.2107483. PubMed DOI
•• Homhuan W, Poomthavorn P, Paksi W, Khlairit P, Nongnuch A, Pirojsakul K. Masked hypertension and its associations with glycemic variability metrics in children and adolescents with type 1 diabetes. Pediatric Nephrology. 2021;36:379–86. Recent study on masked hypertension in children with diabetes. PubMed
Glackin S, Islam N, Henderson A, Dionne J, Harris K, Panagiotopoulos C, Devlin A. Ambulatory blood pressure and carotid intima media thickness in children with type 1 diabetes. Pediatr Diabetes. 2019;21:358–365. doi: 10.1111/pedi.12960. PubMed DOI
Lurbe E, Redon J, Kesani A, Pascual J, Tacons J, Alvarez V, Batlle D. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002;347:797–805. doi: 10.1056/NEJMoa013410. PubMed DOI
Brunvand L, Heier M, Brunborg C, Hanssen K, Fugelseth D, Stensaeth K, Dahl-Jørgensen K, Margeirsdottir H. Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function. BMC Cardiovasc Dis. 2017;17. 10.1186/s12872-017-0551-0 PubMed PMC
Franklin S, Thijs L, Li Y, Hansen T, Boggia J, Liu Y, Asayama K, et al. Hypertension 2013;61. 10.1161/HYPERTENSIONAHA.111.00289
Mahfouz R, Gouda M, Alawady W. Determinants and impact of masked hypertension in offspring of patients with diabetes: relation with coronary flow and cardiac function. Blood Press. 2019;28:57–63. doi: 10.1080/08037051.2018.1524261. PubMed DOI
Cioana M, Deng J, Hou M, Nadarajah A, Qiu Y, Chen S, Rivas A, Banfield L, Chanchlani R, Dart A, Wicklow B, Alfaraidi H, Alotaibi A, Thabane L, Samaan M. Prevalence of hypertension and albuminuria in pediatric type 2 diabetes. JAMANetwork Open. 2021;4. 10.1001/jamanetworkopen.2021.6069 PubMed PMC
Brunner E, Shipley M, Ahmadi-Abhari S, Tabak A, McEniery C, Wilkinson I, Marmot M, Singhanoux A, Kivimaki M. Adiposity, obesity, and arterial aging. Hypertension. 2015;66:294–300. doi: 10.1161/HYPERTENSIONAHA.115.05494. PubMed DOI PMC
Özkan S, Ata N, Yavuz B. Increased masked hypertension prevalence in patients with obesity. Clin Exp Hypertens. 2018;40:780–783. doi: 10.1080/10641963.2018.1431262. PubMed DOI
Colantonio L, Anstey D, Carson A, Ogedegbe G, Abdalla M, Sims M, Shimbo D, Muntner P. Metabolic syndrome and masked hypertension among African Americans: the Jackson Heart Study. The Journal of Clinical Hypertension. 2017;19:592–600. doi: 10.1111/jch.12974. PubMed DOI PMC
Lurbe E, Invitti C, Torro I, Maronati A, Aguilar F, Sartorio A, Redon J, Parati G. The impact of the degree of obesity on the discrepancies between office and ambulatory blood pressure values in youth. J Hypertens. 2006;24:1557–1564. doi: 10.1097/01.hjh.0000239291.32883.e3. PubMed DOI
So H, Yip G, Choi K, Li A, Leung L, Wong S, Sung R. Association between waist circumference and childhood-masked hypertension: a community-based study. J Paediatr Child Health. 2016;52:385–390. doi: 10.1111/jpc.13121. PubMed DOI
Kirk V, Midgley J, Giuffre M, Ronksley P, Nettel-Aguirre A, Al-Shamrani A. Hypertension and obstructive sleep apnea in Caucasian children. World J Cardiol. 2010;26(2):251–256. doi: 10.4330/wjc.v2.i8.251. PubMed DOI PMC
Mazo A, Duong MD, Sharma M, Mahgerefteh J, Goilav B. Ambulatory blood pressure patterns in children, adolescents, and young adults with childhood-onset systemic lupus erythematosus and normal office blood pressure. J Clin Rheumatol. 2022;28:328–331. doi: 10.1097/RHU.0000000000001884. PubMed DOI
Centra JC, Roberts G, Opie G, Cheong J, Doyle LW; Masked hypertension in extremely preterm adolescents. Victorian Infant Collaborative Study Group. J Paediatr Child Health. 2015;51:1060–5. PubMed
Limratchapong C, Nuntnarumit P, Paksi W, Pirojsakul K. Current obesity was associated with hypertension in children born very low birth weight. BMC Res Notes. 2021;14:196. doi: 10.1186/s13104-021-05611-x. PubMed DOI PMC
Iturzaeta A, Pompozzi L, Casas Rey C, Passarelli I, Torres F. Prevalence of masked hypertension among children with risk factors for arterial hypertension. Arch Argent Pediatr. 2018;116:328–332. PubMed
•• Thakkar HV, Pope A, Anpalahan M. Masked hypertension: a systematic review. Heart Lung Circ. 2020;29:102–11. Nice recent review on masked hypertension. PubMed
Stergiou GS, Rarra VC, Yiannes NG. Prevalence and predictors of masked hypertension detected by home blood pressure monitoring in children and adolescents: the Arsakeion school study. Am J Hypertens. 2009;22:520. doi: 10.1038/ajh.2009.34. PubMed DOI
Kollios K, Nika T, Kotsis V, Chrysaidou K, Antza C, Stabouli S. Arterial stiffness in children and adolescents with masked and sustained hypertension. J Hum Hypertens. 2021;35:85–93. doi: 10.1038/s41371-020-0318-4. PubMed DOI
Stabouli S, Kotsis V, Zakopoulos N. Ambulatory blood pressure monitoring and target organ damage in pediatrics. J Hypertens. 2007;25:1979–1986. doi: 10.1097/HJH.0b013e3282775992. PubMed DOI
Stabouli S, Kotsis V, Rizos Z, Toumanidis S, Karagianni C, Constantopoulos A, et al. Left ventricular mass in normotensive, prehypertensive and hypertensive children and adolescents. Pediatr Nephrol. 2009;24:1545–1551. doi: 10.1007/s00467-009-1165-2. PubMed DOI
McNiece KL, Gupta-Malhotra M, Samuels J, Bell C, Garcia K, Poffenbarger T, et al. Left ventricular hypertrophy in hypertensive adolescents: analysis of risk by 2004 National High Blood Pressure Education Program Working Group staging criteria. Hypertension. 2007;50:392–395. doi: 10.1161/HYPERTENSIONAHA.107.092197. PubMed DOI PMC
Seeman T, Hradský O, Gilík J. Isolated nocturnal hypertension is associated with increased left ventricular mass index in children. Pediatr Nephrol. 2021;36:1543–1550. doi: 10.1007/s00467-020-04861-4. PubMed DOI
Yam MC, So HK, Kwok SY, Lo FC, Mok CF, Leung CK, et al. Left ventricular mass of persistent masked hypertension in Hong Kong Chinese adolescents: a 4-year follow-up study. Cardiol Young. 2018;28:837–843. doi: 10.1017/S1047951118000434. PubMed DOI
Di Salvo G, Castaldi B, Baldini L, Gala S, del Gaizo F, D'Andrea A, et al. Masked hypertension in young patients after successful aortic coarctation repair: impact on left ventricular geometry and function. J Hum Hypertens. 2011;25:739–745. doi: 10.1038/jhh.2010.118. PubMed DOI
Düzova A, KarabayBayazit A, Canpolat N, Niemirska A, Kaplan Bulut I, Azukaitis K, et al. Isolated nocturnal and isolated daytime hypertension associate with altered cardiovascular morphology and function in children with chronic kidney disease: findings from the Cardiovascular Comorbidity in Children with Chronic Kidney Disease study. J Hypertens. 2019;37:2247–2255. doi: 10.1097/HJH.0000000000002160. PubMed DOI
Chrysaidou K, Kotsis V, Chainoglou A, Tzovaras F, Gidaris D, Chatzipapa N, et al. Impact of ambulatory SBP and overweight on executive function performance in children and adolescents. J Hypertens. 2020;38:1123–1130. doi: 10.1097/HJH.0000000000002371. PubMed DOI
Hata J, Fukuhara M, Sakata S, Arima H, Hirakawa Y, Yonemoto K, Mukai N, Kitazono T, Kiyohara Y, Ninomiya T. White-coat and masked hypertension are associated with albuminuria in a general population: the Hisayama Study. Hypertens Res. 2017;40:937–943. doi: 10.1038/hr.2017.74. PubMed DOI
Ishikawa J, Hoshide S, Eguchi K, Schwartz JE, Pickering TG, Shimada K, Kario K. Masked hypertension defined by ambulatory blood pressure monitoring is associated with an increased serum glucose level and urinary albumin-creatinine ratio. J Clin Hypertens. 2010;12:578–587. doi: 10.1111/j.1751-7176.2010.00286.x. PubMed DOI PMC
Yano Y, Oparil S. Masked hypertension. Curr Hypertens Rep. 2017;19:81. doi: 10.1007/s11906-017-0779-1. PubMed DOI
Mitsnefes MM, Pierce C, Flynn J, Samuels J, Dionne J, Furth S, Warady B, CKiD study group. Can office blood pressure readings predict masked hypertension? Pediatr Nephrol. 2016;31:163–6. PubMed PMC
Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study) Circulation. 2001;104:1385–1392. doi: 10.1161/hc3701.096100. PubMed DOI
Middeke M, Goss F. Masked stress-induced arterial hypertension. Dtsch Med Wochenschr. 2014;139:2447–2450. doi: 10.1055/s-0034-1387421. PubMed DOI
Lurbe E, Thijs L, Torro MI, Alvarez J, Staessen JA, Redon J. Sexual dimorphism in the transition from masked to sustained hypertension in healthy youths. Hypertension. 2013;62:410–414. doi: 10.1161/HYPERTENSIONAHA.113.01549. PubMed DOI
Uzu T, Nakao K, Kume S, Araki H, Isshiki K, Araki S, Kawai H, Ugi S, Kashiwagi A, Maegawa H. High sodium intake is associated with masked hypertension in Japanese patients with type 2 diabetes and treated hypertension. Am J Hypertens. 2012;25:1170–1174. doi: 10.1038/ajh.2012.102. PubMed DOI
Leary AC, Donnan PT, MacDonald TM, Murphy MB. The influence of physical activity on the variability of ambulatory blood pressure. Am J Hypertens. 2000;13:1067–1073. doi: 10.1016/S0895-7061(00)01186-9. PubMed DOI
Hung MH, Shih LC, Wang YC, Leu HB, Huang PH, Wu TC, Lin SJ, Pan WH, Chen JW, Huang CC. Prediction of masked hypertension and masked uncontrolled hypertension using machine learning. Front Cardiovasc Med. 2021;8:778306. doi: 10.3389/fcvm.2021.778306. PubMed DOI PMC
• Bae S, Samuels JA, Flynn JT, Mitsnefes MM, Furth SL, Warady BA, Ng DK; CKiD Study. Machine learning-based prediction of masked hypertension among children with chronic kidney disease. Hypertension. 2022;79:2105–113. Study on a new method for detection of masked hypertension. PubMed PMC
• Penmatsa KR, Biyani M, Gupta A. Masked hypertension: lessons for the future. Ulster Med J. 2020;89:77–82. Beatufil review on masked hypertension and its perspectives. PubMed PMC
•• Antza C, Farmakis I, Doundoulakis I, Akrivos E, Stalikas N, Zafeiropoulos S, Kostopoulos G, Stabouli S, Giannakoulas G, Kotsis V. Reproducibility of masked hypertension and office-based hypertension: a systematic review and meta-analysis. J Hypertens. 2022;40:1053–59. Meta-analysis on reproducibility of masked hypertension. PubMed
Hanevold CD, Miyashita Y, Faino AV, Flynn JT. Changes in ambulatory blood pressure phenotype over time in children and adolescents with elevated blood pressures. J Pediatr. 2020;216:37–43.e2. doi: 10.1016/j.jpeds.2019.09.070. PubMed DOI
• Martinez F, Redon J, Aguilar F, Calderon JM, Lurbe E. Persistence and determinants of blood pressure phenotypes according to office and ambulatory blood pressure measurements in youth. Hypertens Res. 2023. 10.1038/s41440-022-01159-w. Online ahead of print. Study on persistence of masked hypertension over time in children. PubMed
Whelton PK, Carey RM, Aronow WS, Casey DE, Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the american college of cardiology/american heart association task force on clinical practice guidelines. Hypertension. 2018;71:e13–e115. PubMed
Parati G, Agabiti-Rosei E, Bakris GL, Bilo G, Branzi G, Cecchi F, et al. MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol. BMJ Open. 2018;8:e021038. doi: 10.1136/bmjopen-2017-021038. PubMed DOI PMC
Lurbe E, Torró MI, Alvarez J. Ambulatory blood pressure monitoring in children and adolescents: coming of age? Curr Hypertens Rep. 2013;15:143–149. doi: 10.1007/s11906-013-0350-7. PubMed DOI
Awazu M. Isolated nocturnal hypertension in children. Front Pediatr. 2022;10:823414. doi: 10.3389/fped.2022.823414. PubMed DOI PMC